NEUEHEALTH INC (NEUE) Stock Price, Quote, News and Overview
NYSE:NEUE - New York Stock Exchange, Inc. - US10920V4041 - Common Stock - Currency: USD
NEUE Quote, Performance and Key Statistics
NYSE:NEUE (2/21/2025, 8:04:01 PM)
7.35
-0.04 (-0.54%)
The current stock price of NEUE is 7.35 USD. In the past year, price decreased by -2.26%.
NEUE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 16.71 | 429.24B | ||
| ELV | ELEVANCE HEALTH INC | 11.68 | 89.31B | ||
| HUM | HUMANA INC | 15.81 | 30.87B | ||
| CNC | CENTENE CORP | 8.12 | 28.60B | ||
| MOH | MOLINA HEALTHCARE INC | 12.53 | 15.75B | ||
| HQY | HEALTHEQUITY INC | 35.37 | 9.41B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 2.53B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 2.20B | ||
| PGNY | PROGYNY INC | 40 | 1.98B |
Related stock screener links
About NEUE
Company Profile
NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. The company is headquartered in Doral, Florida and currently employs 1,252 full-time employees. The company went IPO on 2021-06-24. The Company’s segments include NeueCare and NeueSolutions. NeueCare segment is a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across the ACA Marketplace, Medicare, and Medicaid. NeueCare delivers in-person and virtual clinical care through its 73 owned primary care clinics within an integrated care delivery system. Its integrated system of care includes embedded pharmacy, laboratory, radiology, and population health focused specialty services. The company offers a one-stop-shop for consumers providing primary care, behavioral health, rotating specialties, pharmacy, radiology, and laboratory services, many times at a single location. NeueSolutions segment is a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers. NeueSolutions serves approximately 62,000 value-based care consumers.
Company Info
NEUEHEALTH INC
9250 Nw 36Th Street, Suite 420
Doral FLORIDA US
Employees: 1252
Company Website: https://www.neuehealth.com/
Investor Relations: https://investors.brighthealthgroup.com/
Phone: 16122381321
NEUEHEALTH INC / NEUE FAQ
What is the stock price of NEUEHEALTH INC today?
The current stock price of NEUE is 7.35 USD. The price decreased by -0.54% in the last trading session.
What is the ticker symbol for NEUEHEALTH INC stock?
The exchange symbol of NEUEHEALTH INC is NEUE and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is NEUE stock listed?
NEUE stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for NEUEHEALTH INC stock?
8 analysts have analysed NEUE and the average price target is 7.14 USD. This implies a price decrease of -2.86% is expected in the next year compared to the current price of 7.35. Check the NEUEHEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NEUEHEALTH INC worth?
NEUEHEALTH INC (NEUE) has a market capitalization of 60.93M USD. This makes NEUE a Micro Cap stock.
How many employees does NEUEHEALTH INC have?
NEUEHEALTH INC (NEUE) currently has 1252 employees.
What are the support and resistance levels for NEUEHEALTH INC (NEUE) stock?
NEUEHEALTH INC (NEUE) has a support level at 7.34 and a resistance level at 7.46. Check the full technical report for a detailed analysis of NEUE support and resistance levels.
Is NEUEHEALTH INC (NEUE) expected to grow?
The Revenue of NEUEHEALTH INC (NEUE) is expected to decline by -26.98% in the next year. Check the estimates tab for more information on the NEUE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NEUEHEALTH INC (NEUE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NEUE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NEUE, evaluating the profitability, health, valuation and growth aspects
- NEUEHEALTH INC (NEUE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEUEHEALTH INC (NEUE) Sales and EPS estimates to see what analysts future expectations are.
- NEUEHEALTH INC (NEUE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEUEHEALTH INC (NEUE) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEUEHEALTH INC (NEUE) Stock Chart to make your own analysis
- NEUEHEALTH INC (NEUE) Latest news and press-releases to stay up to date.
Does NEUEHEALTH INC (NEUE) stock pay dividends?
NEUE does not pay a dividend.
When does NEUEHEALTH INC (NEUE) report earnings?
NEUEHEALTH INC (NEUE) will report earnings on 2025-02-26, after the market close.
What is the Price/Earnings (PE) ratio of NEUEHEALTH INC (NEUE)?
The PE ratio for NEUEHEALTH INC (NEUE) is 5.57. This is based on the reported non-GAAP earnings per share of 1.32 and the current share price of 7.35 USD. Check the full fundamental report for a full analysis of the valuation metrics for NEUE.
What is the Short Interest ratio of NEUEHEALTH INC (NEUE) stock?
The outstanding short interest for NEUEHEALTH INC (NEUE) is 0.26% of its float. Check the ownership tab for more information on the NEUE short interest.
NEUE Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to NEUE. When comparing the yearly performance of all stocks, NEUE is one of the better performing stocks in the market, outperforming 87.01% of all stocks.
NEUE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NEUE. NEUE has a bad profitability rating. Also its financial health evaluation is rather negative.
NEUE Financial Highlights
Over the last trailing twelve months NEUE reported a non-GAAP Earnings per Share(EPS) of 1.32. The EPS increased by 102.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -110.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NEUE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 45% to NEUE. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -216.11% and a revenue growth -26.98% for NEUE